zofenopril has been researched along with Myocardial Infarction in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (32.61) | 18.2507 |
| 2000's | 14 (30.43) | 29.6817 |
| 2010's | 16 (34.78) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Kravchun, PG; Martovytskyi, DV; Shelest, OM | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 4 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD; Omboni, S; Reggiardo, G | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D; Omboni, S; Reggiardo, G | 3 |
| Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
| Borghi, C; Del Corso, F; Pareo, I | 1 |
| Ambrosioni, E; Borghi, C; Campesi, I; Franconi, F; Omboni, S; Reggiardo, G | 1 |
| Ali, MJ; Bradley, JM; Cirino, G; Donnarumma, E; Evangelista, S; Goodchild, TT; Islam, KN; Jenkins, JS; Lefer, DJ; Organ, CL; Patel, RA; Polhemus, DJ; Rushing, AM; Scarborough, AL | 1 |
| Ambrosioni, E; Borghi, C; Cicero, AF | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD | 1 |
| Abuladze, GV; Erkomaishvili, IG; Narsiia, EV; Nebieridze, MI; Pipiia, NG | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
| Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Carubelli, V; Castrini, AI; Dei Cas, L; Inama, L; Lazzarini, V; Lombardi, C; Metra, M | 1 |
| Ambrosioni, E; Borghi, C | 2 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD | 1 |
| Buikema, H; de Zeeuw, D; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 2 |
| Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Batyraliev, TA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Buikema, H | 1 |
| Teyssedou, A | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K | 1 |
| Gurbel, PA; O'Connor, CM | 1 |
| Mikus, G; Mörike, K | 1 |
| Chaudhry, GM; Haneef, N | 1 |
| de Teresa, E | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C | 1 |
| Pfeffer, MA | 1 |
| Ambrosioni, E; Borghi, C; Magnani, B | 4 |
| Ambrosioni, E; Borghi, C; Boschi, S; Branzi, A; Magnani, B; Melandri, G | 1 |
| Ambrosioni, E; Bacchelli, S; Bignamini, A; Borghi, C; Esposti, DD; Magnani, B | 1 |
| Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
| de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| de Graeff, PA; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Bel, KJ; de Graeff, PA; de Langen, CD; Mook, PH; Tio, RA; van Gilst, WH; van Wijngaarden, J; Wesseling, H; Wolters, KG | 1 |
10 review(s) available for zofenopril and Myocardial Infarction
| Article | Year |
|---|---|
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Progression-Free Survival; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Xanthine Oxidase | 2018 |
Evolving concept of cardioprotection in myocardial infarction: from SMILE-1 to SMILE-5.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2013 |
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Control
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
[Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diabetic Cardiomyopathies; Heart Failure; Humans; Hypertension; Myocardial Infarction | 2011 |
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Heart; Humans; Hypertension; Myocardial Infarction | 2004 |
[Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Time Factors; Treatment Outcome | 2006 |
Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia | 2006 |
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction | 1994 |
17 trial(s) available for zofenopril and Myocardial Infarction
| Article | Year |
|---|---|
Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies.
Topics: Aged; Amlodipine; Antihypertensive Agents; Captopril; Data Analysis; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Time-to-Treatment; Treatment Outcome | 2018 |
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Topics: Captopril; Demography; Drug Therapy, Combination; Endpoint Determination; Female; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Myocardial Infarction; Propensity Score; Ramipril; Survival Analysis; Time Factors; Ventricular Dysfunction, Left | 2016 |
Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors | 2017 |
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Comorbidity; Female; Heart Failure; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction | 2008 |
Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cholesterol, LDL; Diagnostic Tests, Routine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Time Factors; Treatment Outcome | 2009 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Hypotension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Recurrence; Survival Rate | 2003 |
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis; Time Factors | 2003 |
Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 2006 |
Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 2007 |
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction; Treatment Outcome | 1995 |
Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome | 1994 |
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Renin; Renin-Angiotensin System | 1993 |
Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prevalence; Prospective Studies; Time Factors | 1996 |
Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome; Ventricular Function, Left | 1999 |
Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
Topics: Administration, Oral; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Placebos; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Safety; Stroke Volume; Treatment Outcome; Vascular Resistance; Ventricular Function, Left | 1991 |
19 other study(ies) available for zofenopril and Myocardial Infarction
| Article | Year |
|---|---|
Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril.
Topics: Captopril; Endostatins; Humans; Insulin-Like Growth Factor I; Myocardial Infarction; Obesity | 2020 |
Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sex Factors; Treatment Outcome | 2014 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Topics: Animals; Antihypertensive Agents; Biological Availability; Blotting, Western; Captopril; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Heart; Hydrogen Sulfide; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Ramipril; Random Allocation; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Sulfurtransferases; Swine; Swine, Miniature; Troponin I | 2016 |
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Early Medical Intervention; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Ramipril; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Risk Factors; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
[Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction; Time Factors | 2012 |
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Kidney; Male; Myocardial Infarction; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Ventricular Function, Left | 2004 |
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Drug Therapy, Combination; Heart Ventricles; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Lisinopril; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Ventricular Function | 2005 |
[ACE inhibitors after myocardial infarction: close-up on zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic | 2007 |
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Controlled Clinical Trials as Topic; History, 20th Century; History, 21st Century; Humans; Hypertension; Myocardial Infarction | 2007 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Humans; Myocardial Infarction | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Myocardial Infarction | 1995 |
[Utilization of angiotensin-converting enzyme inhibitors in anterior infarction without congestive semiology].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
ACE inhibition in acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Myocardial Infarction | 1995 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Heart Ventricles; Male; Myocardial Infarction; Organ Size; Rats; Rats, Inbred Strains; Time Factors | 1991 |
The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Creatine Kinase; Electric Stimulation; Heart; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Purines; Renin; Swine; Tachycardia; Time Factors; Ventricular Function | 1990 |